相关实验视频

Updated: Jul 17, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

在ELN 2022风险分类中,TP53状态和对AML预后的影响

Shaun Fleming^1,2, Xavier Cheng-Hong Tsai³, Rhiannon Morris⁴

¹Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.

|August 30, 2023

概括

这项研究分析了急性髓性白血病 (AML) 风险组中的TP53突变及其预后影响. 它研究了低变异基分数和TP53突变AML中的特定遗传异常的相关性.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

急性髓性白血病 (AML) 是一种异质的血液性恶性瘤.
准确的风险分层对于最佳的AML治疗至关重要.
人们越来越认识到TP53突变在AML预后中的作用.

研究的目的:

为了确定TP53突变在欧洲白血病网2022年AML风险类别中的频率.
为了评估TP53突变变体等位素分数低于10%的预后意义.
评估特异性染色体异常和与髓质疏松症相关的基因突变对TP53-突变AML的影响.

主要方法:

在定义的AML风险组内分析TP53突变频率.
TP53变体的等位素分数 (<10%) 与临床结果的相关性.
基因异常的预后评估 (例如, -7, -5/del(5q), -17/abn(17p,复杂/单体型) 与TP53状态相结合.

主要成果:

在欧洲白血病网 2022 AML 风险分类中,TP53 突变频率有所不同.
一个TP53突变变异型的基分数<10%被评估为其预后相关性.
在TP53突变状态的背景下,分析了特定遗传异常的预后影响.

结论:

TP53突变频率是AML风险分层中的一个关键因素.
低变异的TP53突变的等位基因分数可能具有预后影响.
结合TP53突变的遗传异常显著影响AML的预后.

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...